Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

BACKGROUND: Bone loss and pathological fractures are common skeletal complications associated with androgen deprivation therapy and bone metastases in prostate cancer patients. We have previously demonstrated that prostate cancer cells secrete receptor activator of NF-kB ligand (RANKL), a protein es...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gupta, Aditi, Cao, Wei, Chellaiah, Meenakshi A
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2012
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3499378/ https://ncbi.nlm.nih.gov/pubmed/22966907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-11-66
Tags:	Add Tag No Tags, Be the first to tag this record!

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

Similar Items